Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates Overweight
September 1, 2017 10:04 AM EDTPiper Jaffray lowered its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $41.00 (from $42.00) while maintaining a Overweight rating following the company's 4Q. PAHC reported top and bottom line upside, where revenue of $195M came in above the Street at $192.5M and adjusted... More
